BPC-157 + TB-500 in India

Name: BPC 157 + TB 500 Blend
Brand: Prime Peptide
SKU: PR-BB10
Price: 3999.0 INR
Availability: InStock

PRODUCT OVERVIEW

What is BPC-157 + TB-500?

BPC-157 + TB-500 is a laboratory research blend containing two distinct peptide components. BPC-157 is a defined 15-amino-acid peptide studied in preclinical and in-vitro models involving cellular migration, vascular signaling, nitric-oxide signaling and tissue-response pathways. TB-500 is a commercial research name used for thymosin-beta-4-related peptide materials studied in actin dynamics, cell migration and endothelial signaling; the exact molecular identity of the supplied TB-500 component should be confirmed from batch documentation.

The blend can support controlled study designs involving the research pathways associated with both components, comparative peptide experiments and co-formulation analysis. Evidence associated with the individual components does not by itself establish combination-specific synergy or outcomes.

Purity≥99%

Molecular WeightMixture; TB-500 identity per batch COA

SequenceBPC-157: GEPPPGKPADDAGLV TB-500: verify exact molecular identity and sequence on batch COA

StorageStore refrigerated at 2–8°C

FormLyophilized peptide blend

Research UseFor in-vitro laboratory research only

BPC-157 and TB-500 Multi-Pathway Research Model

The BPC-157 component is connected to research involving tendon fibroblast migration, VEGF-associated angiogenesis and nitric-oxide signaling. The TB-500 component is connected to actin cytoskeleton dynamics, cell migration and tissue-repair signaling, and endothelial migration and angiogenic signaling. These are represented as separate research contexts that can be examined within the same experimental design.

Co-formulation alone does not establish a single blend mechanism, biological synergy or combination-specific outcome. Those conclusions require direct experimental evidence under the relevant study conditions.

GLP-1Receptor

GIPReceptor

GlucagonReceptor

RESEARCH AREAS

BPC-157 + TB-500 Potential Use Cases

Product-specific research applications associated with Prime Peptide BPC-157 + TB-500.

Cellular migration and tissue-response research

Actin cytoskeleton and cell-migration studies

Endothelial and angiogenic-signaling models

Nitric-oxide signaling research

Comparative BPC-157 and TB-500 pathway studies

Co-formulation analytical studies

KEY BENEFITS

BPC-157 + TB-500 Research Highlights

Key research-oriented characteristics connected to Prime Peptide BPC-157 + TB-500.

Two research peptide components in one blend
Supports controlled multi-pathway comparative study designs
Keeps BPC-157 and TB-500 component identities separately traceable
Uses batch-specific TB-500 identity verification instead of unsupported molecular claims

SPECIFICATIONS

BPC-157 + TB-500 Molecular Data

Molecular specifications for Prime Peptide BPC-157 + TB-500
Molecular Formula	Mixture; TB-500 identity per batch COA
Molecular Weight	Mixture; TB-500 identity per batch COA
Purity	≥99%
Appearance	White to off-white lyophilized powder
Solubility	Solubility can depend on the exact TB-500 molecular form, concentration, pH and solvent system. Follow the applicable laboratory protocol and batch documentation.
Storage	Store refrigerated at 2–8°C
Research Use	For in-vitro laboratory research only

3D Structure · Representative Model

BIOLOGICAL & MOLECULAR TARGETS

BPC-157 + TB-500 Research Targets

Tendon fibroblast migration

TF migration

Cellular repair process

Tendon fibroblast migration is a cellular process examined in BPC-157 studies. Published in-vitro work reports increased tendon-explant outgrowth and enhanced migration-related responses without directly increasing fibroblast proliferation.

View reference ↗

VEGF-associated angiogenesis

VEGF pathway

Vascular signaling pathway

VEGF-associated angiogenesis describes vascular remodeling studied in muscle and tendon injury models. BPC-157 research has examined changes in VEGF expression and vessel markers during tissue-repair experiments.

View reference ↗

Nitric oxide signaling

NO signaling

Cellular signaling pathway

Nitric oxide signaling is a vascular and cellular pathway frequently evaluated in BPC-157 preclinical models, including studies measuring eNOS expression and nitric-oxide-related responses during tissue repair.

View reference ↗

Actin cytoskeleton dynamics

Actin dynamics

Cytoskeletal regulatory pathway

Thymosin beta-4 research describes binding to monomeric actin and regulation of actin polymerization, cytoskeletal organization, and cell motility. This pathway is included as literature context for TB-500-related research and does not establish that every material sold as TB-500 is identical to full-length thymosin beta-4.

View reference ↗

Cell migration and tissue-repair signaling

Migration/repair

Cellular repair process

Full-length thymosin beta-4 has been studied in cellular migration, extracellular-matrix remodeling, and wound-repair models. These findings provide cautious pathway context only and should not be transferred automatically to an unspecified TB-500 preparation.

View reference ↗

Endothelial migration and angiogenic signaling

Endothelial migration

Vascular cellular pathway

Thymosin beta-4 has been investigated in endothelial-cell migration and angiogenesis-related experimental systems, including cytoskeletal and PI3K/Akt/eNOS-associated responses. This entry describes the evidence base for thymosin beta-4 rather than proving formulation equivalence with TB-500.

View reference ↗

SCIENTIFIC SOURCES

BPC-157 + TB-500 Citations & References

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

Journal of Applied Physiology 2011

In-vitro and tendon-explant study examining fibroblast outgrowth, cell survival and migration-related responses associated with BPC-157.

Read publication →

Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing

Journal of Physiology and Pharmacology 2010

Preclinical study evaluating VEGF expression and vascular markers in muscle and tendon healing models.

Read publication →

Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing

Cell and Tissue Research 2019

Review of the preclinical literature on BPC-157 and musculoskeletal soft-tissue healing, including tendon, ligament and muscle models.

Read publication →

Thymosin beta4 stimulates directional migration of human umbilical vein endothelial cells

FASEB Journal 1997

Primary endothelial-cell study reporting directional migration responses to thymosin beta-4. This is evidence for full-length thymosin beta-4, not automatic proof of equivalence for products labeled TB-500.

Read publication →

Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta

Experimental Cell Research 2007

Cellular study examining thymosin beta-4-associated epithelial migration and matrix-remodeling responses. It provides mechanistic context for the full-length peptide.

Read publication →

Thymosin beta4 promotes endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway

Journal of Cardiovascular Pharmacology 2009

Preclinical study of endothelial progenitor-cell migration and PI3K/Akt/eNOS-associated signaling in response to thymosin beta-4.

Read publication →

TERMINOLOGY

BPC-157 + TB-500 Glossary

BPC-157 + TB-500 blend — A laboratory research blend containing BPC-157 and TB-500 as separate peptide components for controlled multi-pathway and co-formulation studies.

BPC-157 + TB-500 is a laboratory research blend containing two distinct peptide components. BPC-157 is a defined 15-amino-acid peptide studied in preclinical and in-vitro models involving cellular migration, vascular signaling and tissue-response pathways. TB-500 is a commercial research name used for thymosin-beta-4-related peptide materials studied in actin dynamics, cell migration and endothelial signaling; the exact molecular identity of the supplied TB-500 component should be verified from batch documentation.

The presence of both components in one blend does not by itself establish biological synergy or combination-specific outcomes.

Also known as: BPC-157 + TB-500, BPC 157 + TB 500, BPC-157 TB-500 blend, BPC TB blend

BPC-157 — A synthetic 15-amino-acid peptide commonly described as a stable gastric pentadecapeptide and studied primarily in preclinical models.

BPC-157 is a 15-amino-acid peptide with the sequence GEPPPGKPADDAGLV. Published literature describes it as a stable gastric pentadecapeptide investigated in preclinical and in-vitro models involving tendon, vascular, gastrointestinal and tissue-repair pathways.

Also known as: BPC 157, Body Protection Compound 157, Stable gastric pentadecapeptide Source ↗

Stable gastric pentadecapeptide — A 15-amino-acid gastric peptide fragment described in the scientific literature as BPC-157.

The term stable gastric pentadecapeptide refers to BPC-157, a 15-amino-acid sequence studied in experimental models of tissue repair and gastrointestinal cytoprotection.

Also known as: Gastric pentadecapeptide, BPC-157 Source ↗

Angiogenesis — The formation and remodeling of blood vessels, a process studied in tissue repair and vascular biology.

Angiogenesis is the biological process through which new blood vessels form from existing vascular structures. In BPC-157 research, angiogenesis has been evaluated using VEGF expression and vascular markers in muscle and tendon models.

Also known as: Neovascularization, Vascular growth Source ↗

Tendon fibroblast — A connective-tissue cell involved in tendon extracellular-matrix maintenance and repair responses.

Tendon fibroblasts are cells that maintain and remodel tendon extracellular matrix. BPC-157 studies have examined their survival, migration and outgrowth in tendon-explant and cell-culture models.

Also known as: Tenocyte, Tendon-derived fibroblast Source ↗

TB-500 — A marketplace and research-material name associated with a synthetic thymosin beta-4-related peptide; exact identity and equivalence should be verified from analytical documentation.

TB-500 is commonly described as a synthetic peptide related to thymosin beta-4. However, the name is used inconsistently across suppliers, and published studies on endogenous or recombinant full-length thymosin beta-4 should not automatically be treated as direct evidence for every TB-500 material. Sequence, purity, and identity should be established through product-specific analytical documentation.

Also known as: TB500, thymosin beta-4-related research peptide

Thymosin beta-4 — An endogenous 43-amino-acid actin-binding peptide involved in cytoskeletal organization, cell migration, and tissue-repair research.

Thymosin beta-4 is a naturally occurring 43-amino-acid peptide that binds globular actin and has been studied in cell migration, endothelial biology, inflammation, and tissue-repair models. It must be distinguished from products labeled TB-500 unless analytical evidence establishes the precise molecular identity.

Also known as: Tβ4, TMSB4X peptide Source ↗

Actin sequestration — Reversible binding of monomeric actin that regulates the pool available for filament assembly.

Actin sequestration controls the availability of globular actin for polymerization into filaments. Thymosin beta-4 is a major intracellular actin-sequestering peptide and is therefore studied in cytoskeletal remodeling and motility.

Also known as: G-actin sequestration, actin monomer binding Source ↗

Cell migration — The coordinated movement of cells through changes in cytoskeleton, adhesion, and extracellular-matrix interactions.

Cell migration is a multistep process involving actin remodeling, adhesion turnover, signaling, and interaction with extracellular matrix. It is a common endpoint in thymosin beta-4 tissue-repair and endothelial research.

Also known as: cell motility, cellular migration Source ↗

COMMON RESEARCH QUESTIONS

BPC-157 + TB-500 FAQ

What is the BPC-157 + TB-500 blend?

It is a laboratory research blend containing BPC-157 and TB-500 as two separate peptide components. BPC-157 is a defined 15-amino-acid peptide, while TB-500 is a research-market name for thymosin-beta-4-related peptide material whose exact molecular identity should be confirmed from the supplied batch documentation.

Which research pathways are represented in the BPC-157 + TB-500 blend?

The BPC-157 component is connected to research involving tendon fibroblast migration, VEGF-associated angiogenesis and nitric-oxide signaling. The TB-500 component is connected to actin cytoskeleton dynamics, cell migration and tissue-repair signaling, and endothelial migration and angiogenic signaling. These pathways are represented as separate research contexts rather than a single established blend mechanism.

Does the BPC-157 + TB-500 blend have a single molecular formula or molecular weight?

No. The product is a mixture rather than a single molecule. BPC-157 has its own defined sequence and molecular identity, while the exact molecular identity of the supplied TB-500 component should be verified against the batch COA. A single combined molecular formula or molecular weight would therefore be misleading.

Does combining BPC-157 and TB-500 establish biological synergy?

No. Evidence associated with the individual components can provide context for combination research, but co-formulation alone does not establish biological synergy or blend-specific outcomes. Those conclusions require direct experimental evidence under the relevant study conditions.

BPC 157 + TB 500 Blend

What is BPC-157 + TB-500?

BPC-157 + TB-500 Potential Use Cases

BPC-157 + TB-500 Research Highlights

BPC-157 + TB-500 Molecular Data